CSM
CAMG Solamere Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-26,250
| Closed | -$937K | – | 83 |
|
|
2021
Q1 | $937K | Sell |
26,250
-9,150
| -26% | -$327K | 0.81% | 49 |
|
|
2020
Q4 | $1.3M | Sell |
35,400
-17,629
| -33% | -$647K | 1.09% | 34 |
|
|
2020
Q3 | $2M | Sell |
53,029
-4,117
| -7% | -$155K | 1.12% | 27 |
|
|
2020
Q2 | $2.33M | Sell |
57,146
-57,357
| -50% | -$2.34M | 1.28% | 17 |
|
|
2020
Q1 | $4.34M | Sell |
114,503
-41,888
| -27% | -$1.59M | 2.28% | 6 |
|
|
2019
Q4 | $7.35M | Buy |
156,391
+6,975
| +5% | +$328K | 3.39% | 3 |
|
|
2019
Q3 | $6.37M | Sell |
149,416
-10,878
| -7% | -$464K | 3.19% | 3 |
|
|
2019
Q2 | $6.42M | Buy |
160,294
+5,912
| +4% | +$237K | 2.94% | 6 |
|
|
2019
Q1 | $6.45M | Buy |
154,382
+9,392
| +6% | +$393K | 3.2% | 2 |
|
|
2018
Q4 | $5.54M | Buy |
144,990
+11,114
| +8% | +$425K | 3.09% | 5 |
|
|
2018
Q3 | $5.38M | Buy |
133,876
+20,624
| +18% | +$828K | 2.75% | 5 |
|
|
2018
Q2 | $4.57M | Buy |
113,252
+4,742
| +4% | +$191K | 2.25% | 10 |
|
|
2018
Q1 | $4.24M | Buy |
+108,510
| New | +$4.24M | 1.93% | 10 |
|